日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Long-term data on the proposed adalimumab biosimilar BCD-057 in patients with moderate to severe psoriasis: A randomized controlled trial

针对中重度银屑病患者,拟上市的阿达木单抗生物类似药BCD-057的长期数据:一项随机对照试验

Samtsov, Alexey V; Bakulev, Andrey L; Khairutdinov, Vladislav R; Kokhan, Muza M; Korotaeva, Tat'yana V; Minullin, Iskander K; Vylegzhanina, Olga A; Dubenskiy, Valery V; Khalilov, Bulat V; Khotko, Alkes A; Zykova, Olga S; Chumachenko, Irina V; Lukyanov, Alexander M; Artemeva, Antonina V; Pukhtinskaia, Polina P

Efficacy and Safety of Netakimab, A Novel Anti-IL-17 Monoclonal Antibody, in Patients with Moderate to Severe Plaque Psoriasis. Results of A 54-Week Randomized Double-Blind Placebo-Controlled PLANETA Clinical Trial

Netakimab(一种新型抗IL-17单克隆抗体)治疗中重度斑块状银屑病患者的疗效和安全性:一项为期54周的随机、双盲、安慰剂对照PLANETA临床试验的结果

Puig, Luís; Bakulev, Andrey L; Kokhan, Muza M; Samtsov, Alexey V; Khairutdinov, Vladislav R; Morozova, Maria A; Zolkin, Nikita A; Kuryshev, Ivan V; Petrov, Alexey N; Artemeva, Antonina V; Zinkina-Orikhan, Arina V